Description
Key Trends in Drug-Diagnostic Co-Development
Identifying collaborative opportunities and navigating regulatory challenges
Report Overview
The development of genomics-based ...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
REPORT HIGHTLIGHTS
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
Introduction
Targeted cancer therapies have achieved phenomenal growth, and many MAb-based immunotherapies are blockbusters
or mega-blockbusters. This market success is due not only to ...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
Introduction
This databook provides insight into the top 10 companies in the US life sciences industry in terms of their estimated IT spend.
Scope
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
Euromonitor International's Eye Care in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowin...(more)
Description This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)
Description
In BMI’s Business Environment Ratings table for the 17 countries in the MEA region, Egypt occupies animproved 9th position, up two places in relation to the previous quarter and now, significant...(more)
Description
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with...(more)
Description
Australia’s pharmaceutical market is among the most developed in the Asia-Pacific region. Access tomedication is good across all sections of the population, with per-capita spending calculated a...(more)
Description
The Czech Republic has one of the most developed and technologically advanced pharmaceutical marketsin Central & Eastern Europe (CEE). Despite the impact of the economic downturn, BMI believes thatCze...(more)
Description
The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds...(more)
Description
Introduction
The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer ...(more)
Description
Introduction
Can radical changes to the structures and strategies of pharmaceutical R&D operations—such as
creating more entrepreneurial environments modeled upon biotech companies&mdash...(more)
Description
The present Competitive Intelligence Report about EGF-R agonists and antagonists provides a competitor evaluation in the field of epidermal growth factor receptor (EGF-R; ErbB1) targeting molecules fo...(more)
Description
The Q409 update of BMI’s Philippines Pharmaceuticals & Healthcare report contains for the first time a10-year forecast for medicine expenditure. The US$2.61bn market is forecast to experience sl...(more)
Description
Our forecasts reveal a modest compound annual growth rate (CAGR) of around 9.7% in US dollar termsfor Mexico’s total drug market value, which is forecast to reach US$15.7bn by 2013. Per-capitaph...(more)
Description
REPORT HIGHLIGHTS
Description
The Czech pharmaceutical market is among the most developed in Central and Eastern Europe (CEE).
Harmonised regulations, high per-capita spending and strong growth have attracted pharmaceutical...(more)
Description
STUDY OVERVIEW
With so much riding on the consumers’ acceptance of a product, it is only logical to have in place initiatives that focus on the unfulfilled needs of the consumer populati...(more)
Description
STUDY OVERVIEW
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions - including publication...(more)
Description
The Philippines remains ranked as the 11th most attractive pharmaceutical market among 15 majorcountries in the Asia Pacific region, according to BMI’s Business Environment Rankings for Q309.Nev...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
